Multi-trait Analysis of GWAS (MTAG) of Substance Use Traits Identifies Novel Genetic Loci and Phenomic Associations
Xu, H.; Toikumo, S. I.; Crist, R. C.; Glogowska, K.; Deak, J. D.; Gelernter, J.; Johnson, E. C.; Kranzler, H.; Kember, R. L.
Show abstract
IntroductionA large majority of genome-wide significant (GWS) loci identified for substance use traits (SUTs) in genome-wide association studies (GWAS) have been for alcohol and smoking-related phenotypes. GWAS of opioid use disorder (OUD) and cannabis use disorder (CUD) have lagged those of the two historically legal substances. MethodsWe applied multi-trait analysis of GWAS (MTAG) to 2,888,727 single nucleotide polymorphisms (SNPs) common to GWAS of four SUTs (OUD, CUD, alcohol use disorder [AUD], and smoking initiation [SMK]) in European-ancestry (EUR) subjects. We calculated polygenic risk scores (PRS) for the four traits in an independent sample (i.e., the Yale-Penn sample; N=5,692 EUR) and examined the power increment for each set of MTAG-GWAS summary statistics relative to those of the input GWAS. ResultsMTAG increased the effective sample size for all four SUTs, which showed high pairwise genetic correlations. After clumping, MTAG identified independent GWS SNPs for all 4 traits: 41 SNPs in 36 loci (including 5 novel loci not previously associated with any SUT) for OUD; 74 SNPs in 60 loci (including 4 novel loci) for CUD; 63 SNPs in 52 loci (including 10 novel loci) for AUD; and 183 SNPs in 144 loci (including 8 novel loci) for SMK. In PRS analyses in the Yale-Penn sample, the MTAG-derived PRS consistently yielded more significant associations with both the corresponding substance use disorder diagnosis and multiple related phenotypes than each of the 4 GWAS-derived PRS. ConclusionsMTAG boosted the number of GWS loci for the 4 SUTs, including identifying genes not previously linked to any SUT. MTAG-derived PRS also showed stronger associations with expected phenotypes than PRS for the input GWAS. MTAG can be used to identify novel associations for SUTs, especially those with sample sizes smaller than for historically legal substances.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Leveraging genome-wide data to investigate differences between opioid use vs. opioid dependence in 41,176 individuals from the Psychiatric Genomics Consortium 97%
- Predicting Substance Use Disorders: A Multifactorial Risk Index Combining Clinical, Environmental, and Genetic Risk Factors 96%
- Genome-wide association study of problematic opioid prescription use in 132,113 23andMe research participants of European ancestry 96%
Similar papers in this journal
- Genetic liability for substance use associated with medical comorbidities in electronic health records of African- and European-ancestry individuals 97%
- Neurogenetic and multi-omic sources of overlap among sensation seeking, alcohol consumption, and alcohol use disorder 96%
- Genome-wide analyses reveal novel opioid use disorder loci and genetic overlap with schizophrenia, bipolar disorder, and major depression 96%
Similar papers in this journal
- Multi-trait genome-wide association analyses leveraging alcohol use disorder findings identify novel loci for smoking behaviors in the Million Veteran Program 95%
- Polygenic scores for tobacco use provide insights into systemic health risks in a diverse EHR-linked biobank in Los Angeles 95%
- Distinguishing clinical and genetic risk factors for suicidal ideation and behavior in a diverse hospital population 95%
Similar papers in this journal
- Genetic underpinnings of the transition from alcohol consumption to alcohol use disorder: shared and unique genetic architectures in a cross-ancestry sample 96%
- Genetic Heterogeneity Across Dimensions of Alcohol Use Behaviors 96%
- Multivariate GWAS elucidates the genetic architecture of alcohol consumption and misuse, corrects biases, and reveals novel associations with disease 95%
Similar papers in this journal
- Rare protein coding variants implicate genes involved in risk of suicide death 94%
- Integrative multi-omics analysis of genomic, epigenomic, and metabolomics data leads to new insights for Attention-Deficit/Hyperactivity Disorder 93%
- Genome-wide association analysis reveals extensive genetic overlap between mood instability and psychiatric disorders but divergent patterns of genetic effects 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.